Virtu Financial LLC Cue Biopharma, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$3.11 - $4.91 $54,717 - $86,386	17,594 New	17,594 $64,000
Q3 2021 Nov 12, 2021	SELL	$10.06 - $15.3 $250,363 - $380,771	-24,887 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$10.9 - $14.53 $90,938 - $121,223	8,343 Added 50.43%	24,887 $290,000
Q1 2018 May 14, 2018	BUY	$11.63 - $17.25 $192,406 - $285,384	16,544 New	16,544 $232,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.